$31.90 -0.09 (-0.28%)
2/10/2012 4:00 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Featured Broker Partners


Advertisement